請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/78866
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 謝淑貞 | zh_TW |
dc.contributor.author | 舒暢 | zh_TW |
dc.contributor.author | Chang Shu | en |
dc.date.accessioned | 2021-07-11T15:25:11Z | - |
dc.date.available | 2024-01-11 | - |
dc.date.copyright | 2019-01-08 | - |
dc.date.issued | 2019 | - |
dc.date.submitted | 2002-01-01 | - |
dc.identifier.citation | 于海洋, 张. 唐. 刘. (2013). 5 种常用大鼠骨质疏松动物模型的特点. 国际口腔医学杂志, 40(5), 629-633.
王建楠, & 吳重達. (2004). 續發性骨質疏鬆症的診斷與防治. 基層醫學, 19(11), 258-263. 王键, 龚颜, 曾荣, & 魏劲松. (2013). 去势雌性大鼠骨质疏松模型的研究. 石作励, 乐慧娟, & 胡声宇. (1984). 运动解剖学: 北京: 人民体育出版社. 孙颖, & 孙凌飞. (2003). 骨质疏松模型大鼠骨量及血脂的变化. 中国临床康复, 7(18), 2530-2531. 林映辰. (2016). 建立蝕骨和成骨細胞平台評估具抗骨質疏鬆潛力之食物因子. 臺灣大學食品科技研究所學位論文, 1-107. 陈东, 王连唐, 陈国栋, & 陈子怡. (2002). 去卵巢后大鼠不同部位的骨组织计量学与骨密度研究. 中国骨质疏松杂志, 8(3), 208-210. 钟卫权. (2007). 不同负荷的游泳训练及雌激素对去卵巢大鼠骨质疏松症的影响. 中国组织工程研究与临床康复, 11(17), 3351-3353. 潘震澤, 楊志剛, 高毓儒, 黃娟娟, 謝坤叡, 袁宗凡, . . . 梁淑鈴. (1999). 人體生理學. 台北市: 合記. Aerssens, J., Boonen, S., Lowet, G., & Dequeker, J. (1998). Interspecies differences in bone composition, density, and quality: potential implications for in vivo bone research. Endocrinology, 139(2), 663-670. Altavilla, D., Crisafulli, A., Marini, H., Esposito, M., D'anna, R., Corrado, F., . . . Squadrito, F. (2004). Cardiovascular effects of the phytoestrogen genistein. Current Medicinal Chemistry-Cardiovascular & Hematological Agents, 2(2), 179-186. Arnett, T. (2003). Regulation of bone cell function by acid–base balance. Proceedings of the Nutrition Society, 62(2), 511-520. Austin, L. A., & Heath III, H. (1981). Calcitonin: physiology and pathophysiology. New England Journal of Medicine, 304(5), 269-278. Bitto, A., Burnett, B., Polito, F., Marini, H., Levy, R., Armbruster, M., . . . Antoci, S. (2008). Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol. British journal of pharmacology, 155(6), 896-905. Black, D. M., & Rosen, C. J. (2016). Postmenopausal osteoporosis. New England Journal of Medicine, 374(3), 254-262. Bonaiuti, D., Shea, B., Iovine, R., Negrini, S., Robinson, V., Kemper, H., . . . Cranney, A. (2002). Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev, 3(3). Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003). Osteoclast differentiation and activation. Nature, 423(6937), 337. Cheng, M., Wang, Q., Fan, Y., Liu, X., Wang, L., Xie, R., . . . Sun, W. (2011). A traditional Chinese herbal preparation, Er-Zhi-Wan, prevent ovariectomy-induced osteoporosis in rats. Journal of ethnopharmacology, 138(2), 279-285. Christenson, R. H. (1997). Biochemical markers of bone metabolism: an overview. Clinical biochemistry, 30(8), 573-593. Comelekoglu, U., Bagis, S., Yalin, S., Ogenler, O., Yildiz, A., Sahin, N. O., . . . Hatungil, R. (2007). Biomechanical evaluation in osteoporosis: ovariectomized rat model. Clinical rheumatology, 26(3), 380-384. Cumming, R. G., & Nevitt, M. C. (1997). Calcium for prevention of osteoporotic fractures in postmenopausal women. Journal of bone and mineral research, 12(9), 1321-1329. Dixon, R. A., & Ferreira, D. (2002). Genistein. Phytochemistry, 60(3), 205-211. Halleen, J. M., Tiitinen, S. L., Ylipahkala, H., Fagerlund, K. M., & Vaananen, H. K. (2006). Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Clinical laboratory, 52(9-10), 499-510. Harris, S. T., Watts, N. B., Genant, H. K., & et al. (1999). Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial. JAMA, 282(14), 1344-1352. doi:10.1001/jama.282.14.1344 Harrop, J. S., Prpa, B., Reinhardt, M. K., & Lieberman, I. (2004). Primary and secondary osteoporosis' incidence of subsequent vertebral compression fractures after kyphoplasty. Spine, 29(19), 2120-2125. Hellekson, K. L. (2002). NIH releases statement on osteoporosis prevention, diagnosis, and therapy. American family physician, 66(1), 161-162. Heshmati, H. M., & Khosla, S. (1998). Idiopathic osteoporosis: a heterogeneous entity. Paper presented at the Annales de medecine interne. Howe, T. E., Shea, B., Dawson, L. J., Downie, F., Murray, A., Ross, C., . . . Creed, G. (2011). Exercise for preventing and treating osteoporosis in postmenopausal women. The Cochrane Library. Huang, T.-H., Hsieh, S. S., Liu, S.-H., Chang, F.-L., Lin, S.-C., & Yang, R.-S. (2010). Swimming training increases the post-yield energy of bone in young male rats. Calcified tissue international, 86(2), 142-153. Iscan, M. Y., & Steyn, M. (2013). The human skeleton in forensic medicine: Charles C Thomas Publisher. Johnell, O., & Kanis, J. (2006). An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis international, 17(12), 1726-1733. Kanis, J., & Group, W. H. O. S. (2007). WHO technical report. University of Sheffield, UK, 66. Kanis, J. A., Melton, L. J., Christiansen, C., Johnston, C. C., & Khaltaev, N. (1994). The diagnosis of osteoporosis. Journal of bone and mineral research, 9(8), 1137-1141. Kwon, S. H., Kang, M. J., Huh, J. S., Ha, K. W., Lee, J. R., Lee, S. K., . . . Lee, M. W. (2007). Comparison of oral bioavailability of genistein and genistin in rats. International journal of pharmaceutics, 337(1), 148-154. Lamartiniere, C. A. (2000). Protection against breast cancer with genistein: a component of soy. The American journal of clinical nutrition, 71(6), 1705s-1707s. Lima, S. Q., Hromádka, T., Znamenskiy, P., & Zador, A. M. (2009). PINP: a new method of tagging neuronal populations for identification during in vivo electrophysiological recording. PloS one, 4(7), e6099. Lu, Y., Genant, H. K., Shepherd, J., Zhao, S., Mathur, A., Fuerst, T. P., & Cummings, S. R. (2001). Classification of osteoporosis based on bone mineral densities. Journal of bone and mineral research, 16(5), 901-910. Messina, M. J., Persky, V., Setchell, K. D., & Barnes, S. (1994). Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutrition and cancer, 21(2), 113-131. Miller, P. D., Zapalowski, C., Kulak, C. A., & Bilezikian, J. P. (1999). Bone densitometry: the best way to detect osteoporosis and to monitor therapy. The Journal of Clinical Endocrinology & Metabolism, 84(6), 1867-1871. Morse, J. H., Horn, E. M., & Barst, R. J. (1999). Hormone replacement therapy. Chest, 116(3), 847-847. Orimo, H., Hayashi, Y., Fukunaga, M., Sone, T., Fujiwara, S., Shiraki, M., . . . Nishimura, J. (2001). Diagnostic criteria for primary osteoporosis: year 2000 revision. Journal of bone and mineral metabolism, 19(5), 331-337. Orwoll, E., Scheele, W., Paul, S., Adami, S., Syversen, U., Diez‐Perez, A., . . . Gaich, G. (2003). The effect of teriparatide [human parathyroid hormone (1–34)] therapy on bone density in men with osteoporosis. Journal of bone and mineral research, 18(1), 9-17. Riggs, B. L. (2012). Age-related osteoporosis. Nutrition and Aging, 207. Riggs, B. L., Wahner, H. W., Seeman, E., Offord, K. P., Dunn, W. L., Mazess, R. B., . . . Melton, L. J. (1982). Changes in Bone Mineral Density of the Proximal Femur and Spine with Aging: DIFFERENCES BETWEEN THE POSTMENOPAUSAL AND SENILE OSTEOPOROSIS SYNDROMES. Journal of Clinical Investigation, 70(4), 716-723. Salakka, A. K., Jokela, T. H., & Wähälä, K. (2006). Multiple hydride reduction pathways in isoflavonoids. Beilstein journal of organic chemistry, 2(1), 16. Sarkar, F. H., & Li, Y. (2002). Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer and Metastasis Reviews, 21(3-4), 265-280. SAVILLE, P. D. (1969). Changes in skeletal mass and fragility with castration in the rat: a model of osteoporosis. Journal of the American Geriatrics Society, 17(2), 155-166. Solomon, E. P., & Davis, P. W. (1983). Human anatomy & physiology: Saunders College Publishing. Tate, M. L. K., Adamson, J. R., Tami, A. E., & Bauer, T. W. (2004). The osteocyte. The international journal of biochemistry & cell biology, 36(1), 1-8. Valles, S. L., Dolz-Gaiton, P., Gambini, J., Borras, C., LLoret, A., Pallardo, F. V., & Viña, J. (2010). Estradiol or genistein prevent Alzheimer's disease-associated inflammation correlating with an increase PPARγ expression in cultured astrocytes. Brain research, 1312, 138-144. Wang, S.-T., Fang, T.-F., Hsu, C., Chen, C.-H., Lin, C.-J., & Su, N.-W. (2015). Biotransformed product, genistein 7-O-phosphate, enhances the oral bioavailability of genistein. Journal of Functional Foods, 13, 323-335. Weiss, L. K., Burkman, R. T., Cushing-Haugen, K. L., Voigt, L. F., Simon, M. S., Daling, J. R., . . . Marchbanks, P. A. (2002). Hormone replacement therapy regimens and breast cancer risk. Obstetrics & Gynecology, 100(6), 1148-1158. Whitaker, M., Guo, J., Kehoe, T., & Benson, G. (2012). Bisphosphonates for osteoporosis—where do we go from here? New England Journal of Medicine, 366(22), 2048-2051. | - |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/78866 | - |
dc.description.abstract | 骨質疏鬆症 (Osteoporosis, OP) 是一種因骨骼強度減弱致使個人增加骨折危險性的疾病。絕經後骨質疏鬆症,又稱為第一型骨質疏鬆症,常見於停經後的婦女,其主要的致病原因是雌激素缺乏所導致的骨吸收增加。金雀異黃酮 (Genistein) 是大豆異黃酮中的一種主要活性成分,廣泛存在於豆類、穀類、水果、蔬菜等300多種植物中。其化學結構相似於卵巢分泌的17β-雌二醇,因此具備類雌激素活性的生理功能。然而,金雀異黃酮的生物可利用率較低,已有研究利用納豆菌發酵進行生物轉換,在其結構中加入磷酸根,形成金雀異黃酮磷酸酯 (Genistein 7- O-phosphate,G7P) ,可大幅提升化合物之水溶性而增加生物可利用率,從而增進其抗骨質疏鬆的潛力。規律且持續的運動也能避免骨質流失,甚至可以增加骨骼中礦物質的含量,提高骨骼強度。游泳是一種全身性的運動,可以讓人體全身的骨骼與肌肉得到協調性的鍛鍊,並且由於水中浮力的存在使得關節的承重降低,因而有保護關節的作用。
本實驗以卵巢摘除母鼠模式模擬絕經後骨質疏鬆症,在誘導骨鬆13週後各處理組分別管餵G7P、游泳訓練和兩者加成,與控制組做比較,探討兩者對於骨質疏鬆的治療是否具有協同作用。實驗結束後用ELISA法測血清中骨轉換指標PINP、TRAcP 5b的濃度,用微電腦斷層掃描儀測定股骨特定部位的BMD以及TB的相關指標,用股骨的組織病理切片來評估骨組織結構變化以及使用骨應力測驗機來測定脛骨的生物力學特性。實驗結果顯示,與Sham組相比,OVX組各項骨指標降低,造成骨質疏鬆的發生。G7P的攝取對於骨質的改善效果不明顯,部分指標來看甚至會加重骨質疏鬆的情形,而游泳訓練對於骨鬆有改善的趨勢,但是G7P加上游泳訓練組別相較於兩個單一處理組有更佳的骨質改善效果,特別是在股骨微電腦斷層掃描圖、股骨組織病理切片和脛骨生物力學上都有統計意義上的差異。因此,後續的研究可以從機制上探討為何游泳訓練和G7P對卵巢摘除大鼠骨質疏鬆有協同的治療效果。 | zh_TW |
dc.description.abstract | Osteoporosis is a disease that increases the risk of fractures due to reduced bone strength. Postmenopausal osteoporosis, also known as type I osteoporosis, is commonly found in menopausal women whose major pathogenic factor is estrogen deficiency, leading to an increase in bone resorption. Genistein is one of the main active compounds among soybean isoflavones, which is widely found in more than 300 kinds of plants such as legumes, cereals, fruits and vegetables. Its chemical structure is similar to the 17β-estradiol secreted by ovaries, and thus contributes to its estrogen-like physiological function. The low bioavailability of genistein could be improved through biotransformation that is carried out using Bacillus subtilis fermentation. A phosphate group is added to its original structure to form genistein 7-O-phosphate (G7P); the higher water solubility and increased bioavailability makes it a potential anti-osteoporotic material. Regular and sustained exercise can also reduce bone loss, and even can improve bone strength by increasing the bone minerals. Swimming is one of the exercises that can move most parts of bones and muscles, thus improving overall coordination. Study also showed that buoyancy in water could help in protecting the joints through the reduction of joint load.
In this study, ovariectomized (OVX) rats were used to model postmenopausal osteoporosis. After 13 weeks of induction, oral administration of G7P, swimming training and their combination were applied to rats daily to investigate whether the combination of oral administration with G7P and swimming training has a synergistic effect on preventing postmenopausal osteoporosis. At the end of the experiment, the levels of bone turnover markers PINP and TRAcP 5b were measured by ELISA. BMD and TB related indexes were determined by microcomputed tomography. The changes of bone structure were evaluated by histological sections of femur and bone stress tester was used to determine the biomechanical properties of the tibia. Experimental results showed that bone indicators of OVX group decreased and resulted in the occurrence of osteoporosis compared with sham group. Swimming training alone showed a positive trend for attenuating bone loss compared with OVX control, whereas treatment of G7P alone did not showed any significant improvement on postmenopausal osteoporosis. However, the combination of G7P and swimming training significantly improved bone indices compared to two other groups, showing significant differences in parameters measured by femoral microcomputed tomography, femoral histomorphometry and tibial biomechanics. Hence, this study can be used as a starting point to further explore the mechanism on how the combination of G7P together with swimming training improve osteoporosis in the ovariectomized rat model. | en |
dc.description.provenance | Made available in DSpace on 2021-07-11T15:25:11Z (GMT). No. of bitstreams: 1 ntu-108-R04641042-1.pdf: 3849827 bytes, checksum: fa421d1a16f9d2878adc0522081adf27 (MD5) Previous issue date: 2019 | en |
dc.description.tableofcontents | 第一章 前言 1
第二章 文獻回顧 1 第一節、骨骼……… 2 一、 骨骼的定義 2 二、 骨骼的化學組成 2 三、 骨骼的形狀 2 四、 骨骼的結構 2 五、 骨細胞 3 六、 骨代謝 4 第二節、骨質疏鬆症 5 一、 骨質疏鬆症的定義 5 二、 骨質疏鬆症的分類 5 三、 骨質疏鬆症的盛行率 7 四、 骨質疏鬆症的診斷方法 7 五、 骨質疏鬆症的預防和治療方法 8 第三節、動物試驗模式 11 一、 基本介紹 11 二、 去勢大鼠骨質疏鬆模型 11 第四節、金雀異黃酮 12 一、 基本介紹 12 二、 功效作用 13 三、 化學修飾 14 第五節、游泳訓練與骨質疏鬆的關係 15 第二章、研究目的與實驗架構 16 第一節、研究目的 16 第二節、實驗架構 16 第三章、材料與方法 17 第一節、動物實驗設計 17 一、 實驗動物飼養 17 二、 去勢大鼠模型建立 17 三、 尾動脈採血 20 四、樣品介入 21 五、游泳訓練 22 第二節、骨代謝血液生化指標測定 23 一、 骨形成指標PINP 23 二、 骨吸收指標TRAcP 5b 24 第三節、股骨微電腦斷層掃描測定 25 一、 實驗原理 25 二、 實驗儀器 25 三、 實驗方法 26 第四節、脛骨生物力學特性分析 26 一、 三點彎曲試驗 26 二、 實驗儀器 27 三、 實驗方法 27 第五節、股骨組織切片病理學分析 28 第六節、統計方法 29 第四章、實驗結果 29 第一節、G7P攝入和游泳訓練對卵巢摘除大鼠體重與攝食量之影響 29 一、 G7P攝入和游泳訓練對卵巢摘除大鼠體重之影響 29 二、 G7P攝入和游泳訓練對卵巢摘除大鼠攝食量之影響 30 第二節、G7P攝入和游泳訓練對卵巢摘除大鼠臟器重量之影響 32 一、 G7P攝入和游泳訓練對卵巢摘除大鼠子宮重量之影響 33 二、 G7P攝入和游泳訓練對卵巢摘除大鼠腎周脂肪重量之影響 33 三、 G7P攝入和游泳訓練對卵巢摘除大鼠肝臟、腓腸肌、腎臟重量影響 33 第三節、G7P攝入和游泳訓練對卵巢摘除大鼠血清中骨代謝指標之影響 37 一、 G7P攝入和游泳訓練對卵巢摘除大鼠血清中PINP的影響 37 二、 G7P攝入和游泳訓練對卵巢摘除大鼠血清中TRAcP 5b的影響 37 第四節、股骨組織切片病理切片分析 40 第五節、G7P攝入和游泳訓練對卵巢摘除大鼠骨組織微結構的影響 47 第五章、實驗討論 56 第六章、實驗結論 59 第七章、參考文獻 60 第八章、附圖 67 第九章、附表 72 | - |
dc.language.iso | zh_TW | - |
dc.title | 探討化學修飾之金雀異黃酮與游泳訓練對於卵巢摘除大鼠骨質疏鬆的影響 | zh_TW |
dc.title | Effect on Chemically Modified Genistein and Swimming Training on Ovariectomy-induced Osteoporosis | en |
dc.type | Thesis | - |
dc.date.schoolyear | 107-1 | - |
dc.description.degree | 碩士 | - |
dc.contributor.coadvisor | 潘敏雄 | zh_TW |
dc.contributor.coadvisor | ; | en |
dc.contributor.oralexamcommittee | 黃智興;郭靜娟 | zh_TW |
dc.contributor.oralexamcommittee | ;; | en |
dc.subject.keyword | 絕經後骨質疏鬆症,金雀異黃酮磷酸酯,游泳訓練,協同作用, | zh_TW |
dc.subject.keyword | postmenopausal osteoporosis,G7P,swimming training,synergistic effect, | en |
dc.relation.page | 72 | - |
dc.identifier.doi | 10.6342/NTU201900023 | - |
dc.rights.note | 未授權 | - |
dc.date.accepted | 2019-01-07 | - |
dc.contributor.author-college | 生物資源暨農學院 | - |
dc.contributor.author-dept | 食品科技研究所 | - |
顯示於系所單位: | 食品科技研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-107-1.pdf 目前未授權公開取用 | 3.76 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。